Cancer survival probability as a function of ego defense (adaptive) mechanisms versus depressive symptoms

Psychosomatics

Volumn 47, Issue 3, 2006, Pages 247-253

  Beresford, Thomas P ^a   Alfers, Julie ^a   Mangum, Laura ^a   Clapp, Lori ^a   Martin, Brandon ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BONE CANCER; BRAIN CANCER; BREAST CANCER; CANCER; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DEFENSE MECHANISM; DEPRESSION; DIGESTIVE SYSTEM CANCER; DISTRESS SYNDROME; HEART CANCER; HODGKIN DISEASE; HUMAN; LEUKEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVARY CANCER; PHARYNX CANCER; PROBABILITY; PROSTATE CANCER; QUESTIONNAIRE; SCORING SYSTEM; SKIN CANCER; SPINAL CORD CANCER; UROGENITAL TRACT CANCER; UTERINE CERVIX CANCER; ADAPTIVE BEHAVIOR; BEHAVIOR THERAPY; COMPARATIVE STUDY; EGO; FEMALE; MIDDLE AGED; MORTALITY; NEOPLASM; PATHOLOGY; PATIENT ATTITUDE; PROGNOSIS; PSYCHOLOGICAL ASPECT; RISK FACTOR; SURVIVAL;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; BEHAVIOR THERAPY; DEFENSE MECHANISMS; DEPRESSION; EGO; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PROBABILITY; PROGNOSIS; RISK FACTORS; SICK ROLE; SURVIVAL ANALYSIS;

EID: 33745963850     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.47.3.247     Document Type: Article

References (31)

1. Fawzy FI, Cousins N, Fawzy NW, et al: Structured psychiatric intervention for cancer patients, I: changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 1990; 47:720-725
2. Spiegel D, Bloom JR, Kraemer HC, et al: Effect of psychosocial treatment on survival of patients with metastatic breast cancer (comment). Lancet 1989; 2:888-891
3. Goodwin PJ, Leszcz M, Ennis M, et al: The effect of group psychosocial support on survival in metastatic breast cancer (comment). N Engl J Med 2001; 345:1719-1726
4. Spiegel D: Effects of psychotherapy on cancer survival. Nat Rev Cancer 2002; 2:383-389
5. Buckley P, Conte HR, Plutchik R, et al: Psychodynamic variables as predictors of psychotherapy outcome. Am J Psychiatry 1984; 141:742-748
6. Conte HR, Plutchik R, Buck L, et al: Interrelations between ego functions and personality traits: their relation to psychotherapy outcome. Am J Psychotherapy 1991; 45:69-77
7. Vaillant GE: An empirically-derived hierarchy of adaptive mechanisms and its usefulness as a potential diagnostic axis. Acta Psychiatr Scand Suppl 1985; 319:171-180
8. Perry J: Psychological defense mechanisms in the study of affective and anxiety disorders, in Comorbidity in Anxiety and Mood Disorders. Edited by Maser J, Cloninger C. Washington, DC, American Psychiatric Press, 1990, pp 545-562
9. Akkerman K, Carr V, Lewin T: Changes in ego defenses with recovery from depression. J Nerv Ment Dis 1992; 180:634-638
10. Akkerman K, Lewin TJ, Carr VJ: Long-term changes in defense style among patients recovering from major depression. J Nerv Ment Dis 1999; 187:80-87
11. Perry J, Hoglend P, Shear K, et al: Field trial of a diagnostic axis for defense mechanisms for DSM-IV. J Personal Disord 1998; 12:1-13
12. Soldz S, Vaillant GE: A 50-year longitudinal study of defense use among inner-city men: a validation of DSM-IV defense axis. J Nerv Ment Dis 1998; 186:104-111
13. Vaillant GE: Theoretical hierarchy of adaptive ego mechanisms: a 30-year follow-up of 30 men selected for psychological health. Arch Gen Psychiatry 1971; 24:107-118
14. Trzepacz PT, Baker RW, Greenhouse J: A symptom rating scale for delirium. Psychiatry Res 1988; 23:89-97
15. Melzack R: The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1:277-299
16. Beck AT, Steer RA: Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 1984; 40:1365-1367
17. Andrews G, Singh M, Bond M: The Defense Style Questionnaire. J Nerv Ment Dis 1993; 181:246-256
18. Bond M, Gardner ST, Christian J, et al: Empirical study of self-rated defense styles. Arch Gen Psychiatry 1983; 40:333-338
19. Bond M, Perry J, Gautier M, et al: Validating the self-report of defense styles. J Personal Disord 1989; 3:101-112
20. Perry JC, Hoglend P: Convergent and discriminant validity of overall defensive functioning. J Nerv Ment Dis 1998; 186:529-535
21. Andrews G, Pollock C, Stewart G: The determination of defense style by questionnaire. Arch Gen Psychiatry 1989; 46:455-460
22. Perry JC, Hoglend P, Shear K, et al: Field trial of a diagnostic axis for defense mechanisms for DSM-IV. J Personal Disord 1998; 12:56-68
23. Fleming TR, Lin DY: Survival analysis in clinical trials: past developments and future directions. Biometrics 2000; 56:971-983
24. Vaillant GE: The Wisdom of the Ego. Cambridge, MA, Harvard University Press, 1995
25. Watson M, Greer S, Rowden L, et al: Relationships between emotional control, adjustment to cancer, and depression and anxiety in breast cancer patients. Psychol Med 1991; 21:51-57
26. Lampic C, Wennberg A, Schill JE, et al: Coping, psychosocial well-being, and anxiety in cancer patients at follow-up visits. Acta Oncol 1994; 33:887-894
27. Holland JC, Romano SJ, Heiligenstein JH, et al: A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psycho-Oncology 1998; 7:291-300
28. Costa D, Mogos I, Toma T: Efficacy and safety of mianserin in the treatment of depression in women with cancer. Acta Psychiatr Scand Suppl 1985; 320:85-92
29. Pezzella G, Moslinger-Gehmayr R, Contu A: Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast Cancer Res Treat 2001; 70:1-10
30. Razavi D, Allilaire JF, Smith M, et al: The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand 1996; 94:205-210
31. van Heeringen K, Zivkov M: Pharmacological treatment of depression in cancer patients: a placebo-controlled study of mianserin. Br J Psychiatry 1996; 169:440-443